Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465458) titled 'Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients' on March 6.

Study Type: Observational [Patient Registry]

Primary Sponsor: Humanitas Hospital, Italy

Condition: Renal Carcinoma

Intervention: Device: Radiofrequency Ablation (RFA)

Recruitment Status: Not recruiting

Date of First Enrollment: March 2026

Target Sample Size: 226

Countries of Recruitment: Italy Spain Italy Spain

To know more, visit https://clinicaltrials.gov/study/NCT07465458

Published by HT Digital Content Services with permission from Health Daily Digest....